Jiuzhou Zhao Xiang Li Ruizhe Fan Yaping Qin Zhizhong Wang Bo Wang Shaomei Li Jianfeng Fan Xinxin Wu Hongxia Liu Yuping Guan Yinfeng Liang Xiao Zhang Yongjun Guo
10.3389/fphar.2022.1060460
Front Pharmacol
2022 Nov 23;13:1060460.
eml4-alk f1174l s1189c de novo mutation next generation sequencing (ngs) non-small cell lung cancer (nsclc)
CC BY
https://pubmed.ncbi.nlm.nih.gov/36506539/
Case Reports
PMC9727108
36506539
Primary resistance to first- and second-generation ALK inhibitors in a non-small cell lung cancer patient with coexisting ALK rearrangement and an ALK F1174L-cis-S1189C de novo mutation: A case report
2022